## CL: Colgate-Palmolive Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -3.4% below STRENGTH zone (3.0-6.0%); PEG 1.60 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($76.02)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Colgate-Palmolive Company $CL Shares Sold by Hsbc Holdings PLC**
- Source: MarketBeat | 20251130T115055 | Neutral | Relevance: 99%
- Hsbc Holdings PLC reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 35.7% in the second quarter, selling over 1 million shares and retaining 1.9 million shares valued at approximately $173.8 million. Other institutional investors also adjusted their holdings in the company. Colgate-Palmolive reported strong Q3 earnings, beating EPS estimates, and announced a quarterly dividend of $0.52 per share.

**2. Analysts Highlight Colgate-Palmolive's Efforts to Drive Category Growth**
- Source: Finviz | 20251130T190300 | Somewhat-Bullish | Relevance: 98%
- Analysts are recognizing Colgate-Palmolive's efforts to drive category growth and market share gains, highlighting the company's strong performance in Q3 2025 with $5.13 billion in revenue and solid cash generation. Despite a price target cut by Barclays, the company is accelerating its 2030 Strategy to enhance organizational agility and address industry challenges, maintaining its leading position in oral care.

**3. Colgate-Palmolive Company $CL Shares Purchased by New York State Common Retirement Fund**
- Source: MarketBeat | 20251201T115110 | Somewhat-Bullish | Relevance: 98%
- The New York State Common Retirement Fund significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) by 20.0% in Q2, acquiring an additional 204,864 shares, bringing its total holding to 1,226,712 shares valued at approximately $111.5 million. This move represents about 0.15% of the company. The article also details recent analyst ratings, financial performance, and other institutional investment activities for Colgate-Palmolive.

**4. Arrowstreet Capital Limited Partnership Decreases Stock Holdings in Colgate-Palmolive Company $CL**
- Source: MarketBeat | 20251202T082138 | Neutral | Relevance: 98%
- Arrowstreet Capital Limited Partnership reduced its stake in Colgate-Palmolive Company by 3.6% in Q2 2025, selling 247,532 shares, though still holding 6,544,108 shares worth approximately $594.9 million. Meanwhile, OMERS ADMINISTRATION Corp significantly increased its position by 2,890.5%. The stock trades near $80, offers a 2.6% dividend yield, and has a "Moderate Buy" consensus rating from analysts despite recent price target cuts.

**5. Analysts Highlight Colgate-Palmoliveâ€™s Efforts to Drive Category Growth**
- Source: Insider Monkey | 20251130T140300 | Neutral | Relevance: 98%
- Analysts are highlighting Colgate-Palmolive's efforts to accelerate category growth and gain market share, following the company's latest earnings update. Despite Barclays cutting its price target to $80 from $82, the firm maintained an Equal Weight rating, recognizing Colgate-Palmolive's solid revenue growth, strong market leadership in oral care, and robust cash generation in Q3 2025. The company's focus on its 2030 Strategy aims to address industry challenges and leverage opportunities.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | RBC Capital | $88 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | RBC Capital | up | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.07M) |
| Sells | 23 ($1.66M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.3% (+0.2%)
- Blackrock Inc.: 8.6% (+0.5%)
- State Street Corpora: 6.0% (+0.2%)
- Price (T.Rowe) Assoc: 4.0% (-11.5%)
- Geode Capital Manage: 2.7% (+4.1%)

### Key Risks

1. Long-term trend broken: trading 8.9% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.60 elevated, pricing in significant growth expectations. Forward P/E 20.5x stretched relative to 5% growth. Quality metrics strong (ROE 294%, ROA 15%). Balance sheet: $1.1B free cash flow. Insider selling cluster ($1.7M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $62.8B |
| Beta | 0.29 |
| 52W Range | $74.55 - $100.18 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.60 |
| Forward P/E | 20.5 |
| Current P/E | 21.5 |
| YoY Growth | 5.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -0.5% to -3.4% (-2.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.4pp (needs >3.0% for momentum thesis). Underperforming sector by 3.5pp, stock-specific weakness. Below SMA200 (0.91x), long-term trend not supportive. RSI neutral at 49.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -3.37% (CS: 17) | Weak |
| RSI_14 | 49.2 | Neutral |
| MACD Histogram | 0.11 | Bullish |
| vs SMA20 | 0.999x | Below |
| vs SMA50 | 1.004x | Above |
| vs SMA200 | 0.911x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $78.82
- **Stop Loss:** $76.02 (3.6% risk)
- **Target:** $81.62 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 357
- **Position Value:** $28,138.74
- **Portfolio %:** 28.14%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-01-30 (Est: $0.91)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.89 | $0.91 | +2.4% |
| 2025Q2 | $0.89 | $0.92 | +2.8% |
| 2025Q1 | $0.86 | $0.91 | +6.1% |
| 2024Q4 | $0.89 | $0.91 | +2.3% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*